• 
  Marie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier, Clelia Coutzac, Thierry Lecomte, et al.. Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer, 2023, ⟨10.1002/ijc.34414⟩. ⟨hal-03969427⟩
• 
  Laurys Boudin, A de Nonneville, Pascal Finetti, Léna Mescam, A Le Cesne, et al.. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response. Journal of Translational Medicine, 2022, 20 (1), pp.464. ⟨10.1186/s12967-022-03679-y⟩. ⟨hal-03958345⟩
• 
  Violaine Randrian, Simon Pernot, Karine Le Malicot, Vittorio Catena, Isabelle Baumgaertner, et al.. FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. Digestive and Liver Disease, 2022, 54 (7), pp.857-863. ⟨10.1016/j.dld.2022.04.024⟩. ⟨hal-03906999⟩
• 
  Eric Chevet, F Bassal, Stéphanie Beq, Benjamin Bonhomme, Emeric Boisteau, et al.. AGR2 protein expression in colorectal tumour epithelialcompartment. Gut, 2022, pp.gutjnl-2022-328739. ⟨10.1136/gutjnl-2022-328739⟩. ⟨hal-03930716⟩
• 
  Michael Baboudjian, Pawel Rajwa, Eric Barret, J Beauval, Laurent Brureau, et al.. Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis. European Urology Open Science, 2022, 41, pp.35-44. ⟨10.1016/j.euros.2022.04.012⟩. ⟨hal-03763123⟩
• 
  Diego Teyssonneau, Antoine Thiery-Vuillemin, Charles Dariane, Eric Barret, Jean-Baptiste Beauval, et al.. PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers. Journal of Clinical Medicine, 2022, 11 (6), ⟨10.3390/jcm11061734⟩. ⟨hal-03664794⟩
• 
  Célestin BIGARRÉ, François Bertucci, Pascal Finetti, Gaëtan Macgrogan, Xavier Muracciole, et al.. Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers. 2022. ⟨hal-03936594⟩
• 
  Emeric Boisteau, Céline Posseme, Federico Di Modugno, Julien Edeline, Cédric Coulouarn, et al.. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene, 2022, 41 (42), pp.4673-4685. ⟨10.1038/s41388-022-02452-1⟩. ⟨hal-03798230⟩
• 
  Adolfo Gonzalez Serrano, Marie Laurent, Thomas Barnay, Claudia Martínez-Tapia, Etienne Audureau, et al.. A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis. Journal of Clinical Oncology, 2022, ⟨10.1200/jco.22.01118⟩. ⟨hal-03876999⟩
• 
  M. Debaudringhien, Jean-Yves Blay, André-Michel Bimbai, Sylvie Bonvalot, Antoine Italiano, et al.. Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis. ESMO Open, 2022, 7 (5), pp.100578. ⟨10.1016/j.esmoop.2022.100578⟩. ⟨hal-03837188⟩
• 
  Javier Pascual, Gerhardt Attard, François Clément Bidard, Giuseppe Curigliano, Leticia de Mattos-Arruda, et al.. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Annals of Oncology, 2022, 33 (8), pp.750-768. ⟨10.1016/j.annonc.2022.05.520⟩. ⟨hal-03775791⟩
• 
  Suzy M Scholl, Jonas Beal, Leanne de Koning, Elodie Girard, Marina Popovic, et al.. Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer. EBioMedicine, 2020, 61, pp.103049. ⟨10.1016/j.ebiom.2020.103049⟩. ⟨hal-03492821⟩
• 
  Nadia Younan, Carole Soussain, Sylvain Choquet, Nathalie Cassoux, Valérie Touitou, et al.. Isolated intraocular relapses of primary cerebral lymphomas: An loc network study. Hematological Oncology, 2022, 40 (5), pp.976-986. ⟨10.1002/hon.3044⟩. ⟨hal-03716518⟩
• 
  F. Derquin, A. Floquet, A.C. Hardy-Bessard, J. Edeline, J.P. Lotz, et al.. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network. Gynecologic Oncology, 2020, 158 (3), pp.666-672. ⟨10.1016/j.ygyno.2020.06.491⟩. ⟨hal-02909552⟩
• 
  Paul Lesueur, Gandhi Damaj, Khê Hoang-Xuan, Virginie Roland, Anna Schmitt, et al.. Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study. Blood Advances, 2022, 6 (16), pp.4807 - 4815. ⟨10.1182/bloodadvances.2022007011⟩. ⟨hal-03761560⟩
• 
  Angélique Saint, Ludovic Evesque, Éric François. Les carcinomes épidermoïdes métastatiques du canal anal : prise en charge actuelle et perspectives. Bulletin du Cancer, 2020, 107, pp.792 - 799. ⟨10.1016/j.bulcan.2020.04.016⟩. ⟨hal-03491394⟩
• 
  Noëlle Weingertner, Jean-Pierre Ghnassia, François Le Loarer. Cas no 4 : tumeur épithélioïde des tissus mous. Annales de Pathologie, 2020, 40, pp.275 - 286. ⟨10.1016/j.annpat.2020.01.007⟩. ⟨hal-03492103⟩
• 
  Charles Dariane, Guillaume Ploussard, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau, et al.. Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer : a systematic review and meta-analysis. World Journal of Urology, In press, ⟨10.1007/s00345-022-04087-z⟩. ⟨hal-03752181⟩
• 
  Mégane Le Quang, Dominique Ranchère-Vince, Francois Le Loarer. Aspects morphologiques et moléculaires des tumeurs malignes associées à une dérégulation des complexes BAF. Annales de Pathologie, 2019, 39, pp.399 - 413. ⟨10.1016/j.annpat.2019.05.001⟩. ⟨hal-03488663⟩
• 
  Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, et al.. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. Lancet Oncology, 2019, 20, pp.1740 - 1749. ⟨10.1016/S1470-2045(19)30486-3⟩. ⟨hal-03489049⟩

235

263